The results showed a clear trend of separation between the disease groups (including both treated and untreated patients) and the control group; however, notably, the metabolic profiles of patient samples from the treated and untreated groups largely overlapped ( Supplementary Figures 1A, B ).
← all excerpts
UPLC-MS/MS-based metabolomics analysis identifies disease-associated metabolic signatures of B cells from patients with IgG4-RD.
1
—
—